Global Access Strategies: COVID Vaccines and Other Meds

This Biotech Clubhouse Session will cover insights into best practices for providing access to medicines in the developing from industry experts exploring learnings from Gilead Science’s HIV and Hepatitis C Access to Medicines Program. We take lessons from past efforts, look at the current COVID response, and discuss a path forward for low and middle-income countries’ access to COVID vaccines, as well as future life-saving medicines. Guests: Clifford Samuel, Claudio Lilienfeld, Kash Rangan. Host: Chris Garabedian.  Full auto-generated transcript: click here Originally aired on June 7th, 2021 on Biotech Clubhouse. Shared with permission